The Drug Enforcement Agency has announced plans to begin no earlier than Aug. 1 a pilot test in which data, forms and documents related to the importation and exportation of controlled substances and listed chemicals will be transmitted to the Automated Commercial Environment.
The importation or exportation of these DEA-regulated commodities typically requires the submission of one or more of the following forms.
- DEA Form 35—Permit to Import
- DEA Form 36—Permit to Export
- DEA Form 161—Application for Permit to Export Controlled Substances
- DEA Form 161R—Application for Permit to Export Controlled Substances for Subsequent Reexport
- DEA Form 236—Controlled Substances Import/Export Declaration
- DEA Form 357—Application for Permit To Import Controlled Substances
- DEA Form 486—Import/Export Declaration for List I and List II Chemicals
- DEA Form 486A—Import Declaration for Ephedrine, Pseudoephedrine or Phenylpropanolamine
The upcoming test will involve the electronic transmission of the data contained in these forms to ACE using the partner government agency message set and the transmission of certain DEA permits, forms and documents (including forms 35, 36, 236, 486 and 486A) using the Document Image System. This new capability will satisfy the DEA data and electronic document requirements for any U.S. Customs and Border Protection entry filed electronically in ACE. This test also applies to the exportation of subject commodities and will require the electronic submission of required export data through the Automated Export System or ACE AESDirect using an ACE portal, bulk upload or weblink.
This test will apply to (a) all cargo regulated by DEA as of July 8 that requires a CBP entry or exit, (b) any entry filed in ACE at any port of entry, and (c) cargo imported or exported using any mode of transportation.
Copyright © 2021 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.